We strive to stay at the forefront of biotechnological developments and to constantly incorporate innovation in our offerings – this is essential to be able to develop more reliable drug development platforms and avoid high drug attrition rates. Study director...
Innoser is putting oncology development at the forefront of our efforts this year. By attending this year’s AACR 2021, we hope to improve our innovative oncology offerings and learn from the best. This year the American Association for Cancer Research is hosting...
InnoSer is proud to announce its participation in the annual meeting of the American Association for Cancer Research. As committed contributors to the preclinical oncology field, we look forward to interacting with the community throughout the event. We make this...